Literature DB >> 10202018

The origin and function of soluble CD14 in experimental bacterial meningitis.

A Cauwels1, K Frei, S Sansano, C Fearns, R Ulevitch, W Zimmerli, R Landmann.   

Abstract

Murine experimental meningitis models induced by either Escherichia coli LPS, live Streptococcus pneumoniae, or Listeria monocytogenes were used to study the origin and potential function of soluble CD14 (sCD14) in the brain during bacterial meningitis. Whereas intracerebral infection caused only a minor and/or transient increase of sCD14 levels in the serum, dramatically elevated concentrations of sCD14 were detected in the cerebrospinal fluid. Reverse-transcriptase PCR and FACS analysis of the leukocytes invading the subarachnoid compartment revealed an active amplification of CD14 transcription and concomitant surface expression. These findings were confirmed by in situ hybridization and immunohistochemical analysis. In contrast, parenchymal astrocytes and microglial cells were shown not to significantly contribute to the elevated levels of sCD14. Simultaneous intracerebral inoculation of rsCD14 and S. pneumoniae resulted in a markedly increased local cytokine response. Taken together, these data provide the first evidence that sCD14 can act as an inflammatory co-ligand in vivo. Thus, during bacterial meningitis, sCD14 is massively released by intrathecal leukocytes, and the sCD14 found in the cerebrospinal fluid can play an important role in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202018

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  The role of Toll-like receptors in CNS response to microbial challenge.

Authors:  Gregory W Konat; Tammy Kielian; Ian Marriott
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

2.  Cd14 SNPs regulate the innate immune response.

Authors:  Hong-Hsing Liu; Yajing Hu; Ming Zheng; Megan M Suhoski; Edgar G Engleman; David L Dill; Matt Hudnall; Jianmei Wang; Rosanne Spolski; Warren J Leonard; Gary Peltz
Journal:  Mol Immunol       Date:  2012-03-23       Impact factor: 4.407

3.  Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

Authors:  S P Wiertsema; S-K Khoo; G Baynam; R H Veenhoven; I A Laing; G A Zielhuis; G T Rijkers; J Goldblatt; P N Lesouëf; E A M Sanders
Journal:  Clin Vaccine Immunol       Date:  2006-08

4.  Endotoxin-induced gamma interferon production: contributing cell types and key regulatory factors.

Authors:  Tushar K Varma; Cheng Y Lin; Tracy E Toliver-Kinsky; Edward R Sherwood
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Microglial Heparan Sulfate Proteoglycans Facilitate the Cluster-of-Differentiation 14 (CD14)/Toll-like Receptor 4 (TLR4)-Dependent Inflammatory Response.

Authors:  Paul O'Callaghan; Jin-Ping Li; Lars Lannfelt; Ulf Lindahl; Xiao Zhang
Journal:  J Biol Chem       Date:  2015-04-13       Impact factor: 5.157

6.  Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins.

Authors:  R L Kitchens; P A Thompson; S Viriyakosol; G E O'Keefe; R S Munford
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

7.  Diagnostic accuracy of presepsin (sCD14-ST) for prediction of bacterial infection in cerebrospinal fluid samples from children with suspected bacterial meningitis or ventriculitis.

Authors:  David Stubljar; Andreja Natasa Kopitar; Mojca Groselj-Grenc; Kristina Suhadolc; Teja Fabjan; Miha Skvarc
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

Review 8.  Soluble CD14: role in atopic disease and recurrent infections, including otitis media.

Authors:  Karin C Lødrup Carlsen; Berit Granum
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

9.  Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli.

Authors:  Jai-Wei Lee; Max J Paape; Theodore H Elsasser; Xin Zhao
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain.

Authors:  L Cao; F Y Tanga; J A Deleo
Journal:  Neuroscience       Date:  2008-10-07       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.